Federal Register #DEA-1442

DEA Temporary Placement of 2-Fluorodeschloroketamine in Schedule I

This regulatory action by the Drug Enforcement Administration (DEA) addresses the temporary scheduling of 2-fluorodeschloroketamine (2-FDCK) as a Schedule I controlled substance. - Government Buyer: - Drug Enforcement Administration (DEA), under the Justice Department - OEMs and Vendors: - No OEMs or commercial vendors are involved; this is not a procurement opportunity - Products/Services Requested: - No products or services are being procured - Unique or Notable Requirements: - All persons handling 2-FDCK (including its salts, isomers, and salts of isomers) must comply with Schedule I controls - Mandatory registration, inventory, recordkeeping, reporting, security, labeling, packaging, quota, order form, and import/export regulations for DEA registrants - Administrative, civil, and criminal sanctions apply for non-compliance - The action is based on findings that 2-FDCK poses an imminent hazard to public safety and has no accepted medical use in the U.S.

Description

The Drug Enforcement Administration (DEA) issues a temporary order to place 2-fluorodeschloroketamine (2-FDCK), including its salts, isomers, and salts of isomers, in Schedule I of the Controlled Substances Act. This action is based on the finding that scheduling 2-FDCK is necessary to avoid an imminent hazard to public safety. The order imposes regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I substances on persons who handle or propose to handle this substance. The temporary scheduling is effective from May 22, 2026, until May 22, 2028.

View original listing